Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 79-85

  Sheppard, John D ^a   Nguyen, Quan Dong ^b   Usner, Dale W ^c   Comstock, Timothy L ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BAUSCH AND LOMB   (United States)

Author keywords

Cataract surgery; Glaucoma; Intraocular pressure; Posterior chamber inflammation; Steroid implant; Visual acuity

Indexed keywords

FLUOCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT EXTRACTION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHAKIC INTRAOCULAR LENS; POSTERIOR EYE CHAMBER; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA DETACHMENT; SCHOOL CHILD; UVEITIS; VISUAL ACUITY;

EID: 84857017431     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S24397     Document Type: Article

References (14)

1. Becker MD, Smith JR, Max R, Fiehn C. Management of sightthreatening uveitis: new therapeutic options. Drugs. 2005;65(4): 497-519.
2. Callanan DG, Jaffe GJ, Martin DF, Pearson A, Comstock TL. Treatment of posterior uveitis with a fluocinolone acetonide implant. Arch Ophthalmol. 2008;126(9):1191-1201.
3. Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000;107(11):2024-2033.
4. Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology. 2005; 112(7):1192-1198.
5. Kimura SJ, Thygeson P, Hogan MJ. Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis. Am J Ophthalmol. 1959;47(5 Part 2):171-176.
6. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467-471.
7. Molteno AC, Bosma NJ, Kittelson JM. Otago glaucoma surgery outcome study: long-term results of trabeculectomy - 1976 to 1995. Ophthalmology. 1999;106(9):1742-1750.
8. Park UC, Ahn JK, Park KH, Yu HG. Phacotrabeculectomy with mitomycin C in patients with uveitis. Am J Ophthalmol. 2006; 142(6):1005-1012.
9. Okhravi N, Lightman SL, Towler HM. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology. 1999; 106(4):710-722.
10. Estafanous MF, Lowder CY, Meisler DM, Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol. 2001; 131(5):620-625.
11. Ganesh SK, Babu K, Biswas J. Phacoemulsification with intraocular lens implantation in cases of pars planitis. J Cataract Refract Surg. 2004; 30(10):2072-2076.
12. Kawaguchi T, Mochizuki M, Miyata K, Miyata N. Phacoemulsification cataract extraction and intraocular lens implantation in patients with uveitis. J Cataract Refract Surg. 2007; 33(2):305-309.
13. Ganesh SK, Padmaja Babu K, Biswas J. Cataract surgery in patients with Vogt-Koyanagi-Harada syndrome. J Cataract Refract Surg. 2004; 30(1):95-100.
14. Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol. 2007; 125(11):1478-1485.